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Abstract 19 
 20 
BACKGROUND: Insensitivity of Z. tritici to de-methylation inhibitor (DMI) 21 
and quinone outside inhibitor (QoI) fungicides has been widely reported 22 
from laboratory studies, but the relationships between laboratory 23 
sensitivity phenotype or target site genotype and field efficacy remain 24 
uncertain.  This article reports field experiments quantifying dose 25 
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response curves, and investigates the relationships between field 1 
performance and in vitro EC50 values for DMIs, and frequency of the 2 
G143A substitution conferring QoI resistance.    3 
 4 
RESULTS: Data were analysed from 83 field experiments over 21 years. 5 
Response curves were fitted, expressed as percentage control, rising 6 
towards an asymptote with increasing dose.  Decline in DMI efficacy 7 
over years was associated with a decrease in the asymptote, and 8 
reduced curvature.  Field ED50 values were positively related to in vitro 9 
EC50 values for isolates of Z. tritici collected over a 14 year period.  Loss 10 
of QoI efficacy was expressed through a change in asymptote.  11 
Increasing frequency of G143A was associated with changes in field 12 
dose response asymptotes.   13 
 14 
CONCLUSION:   New resistant strains are often detected by resistance 15 
monitoring and laboratory phenotyped/genotyped before changes in 16 
field performance are detected. The relationships demonstrated here 17 
between laboratory tests and field performance could aid translation 18 
between laboratory and field for other fungicide groups. 19 
 20 
Key words: septoria tritici blotch, Zymoseptoria tritici (Desm.), azole, QoI, 21 
fungicide sensitivity 22 
 23 
1 INTRODUCTION 24 
Fungicides that block metabolic pathways by acting on a single target 25 
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enzyme are prone to loss of efficacy due to resistance evolution in pathogen 1 
populations.  Since the introduction of fungicides to cereal production, four 2 
single-site acting fungicide groups have provided control of Zymoseptoria 3 
tritici (causal organism of septoria tritici blotch; STB), namely: benzimidazoles, 4 
sterol demethylation inhibitors (DMIs), quinone-outside inhibitors (QoIs) and 5 
succinate dehydrogenase inhibitors (SDHIs).  Resistance to benzimidazoles 6 
due to a mutation resulting in the E198A beta-tubulin target site change 7 
developed rapidly in Z. tritici populations in the mid-1980s and resulted in poor 8 
control.1  QoI fungicides demonstrated a high level of activity against STB 9 
when introduced and were widely used in the UK by 1998.2  Resistant strains 10 
carrying a mutation underlying the G143A amino acid substitution in the 11 
cytochrome b target site 3 were first detected in the UK in 2002, although 12 
retrospective studies found G143A in 2001 leaf samples from QoI treated field 13 
plots 4.  In successive years, 2003, 2004 and 2005, the frequency of resistant 14 
isolates in the UK increased rapidly 5 resulting in a severe loss of field efficacy 15 
where QoIs were used alone. The frequency of QoI sensitive strains was 16 
below 5% in UK and Irish populations sampled in 2016 (Fraaije; Kildea, 17 
unpublished data). Isolates carrying cytochrome b F129L alleles have been 18 
detected in Ireland 6 but these strains have not become widespread due to 19 
lower levels of QoI resistance in comparison with G143A strains.  Resistance 20 
against benzimidazoles and QoI can be described as being of a ‘qualitative’, 21 
‘disruptive shift’ or ‘single step’ type, whereby strains carrying a specific target 22 
site mutation of large phenotypic effect cause the population to become 23 
bimodal and rapidly dominate the pathogen population.  24 
The DMI fungicides, in particular the azoles, have been used widely to 25 
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control Z. tritici since their introduction in the 1970s.7  In vitro sensitivity testing 1 
of field Z. tritici isolates with the DMIs epoxiconazole and prothioconazole over 2 
the last 12 years has shown progressive increases in their mean EC50 3 
values.8  Decreased sensitivity has been associated with alteration of the 4 
CYP51 target protein, overexpression of the sterol 14α-demethylase gene 5 
CYP51, and enhanced efflux.8,9,10,11,12,13,14,15,16  DMI resistance can be 6 
described as being of a ‘quantitative’, ‘progressive’ or ‘slow shifting’ type.  The 7 
translation between laboratory tests and field performance is likely to differ 8 
between qualitative and quantitative types of resistance.  9 
For quantitative resistance, such as to the DMIs, changes in in vitro EC50 10 
values should be associated with changes in field efficacy; particularly when 11 
laboratory EC50 values increase substantially, indicating that the field 12 
population has a high frequency of moderately or highly resistant strains.  13 
However, demonstrating a relationship between laboratory sensitivity 14 
phenotype and field performance has proved difficult.  Reductions in in vitro 15 
sensitivity were reported in France and across Europe with epoxiconazole,17 16 
but these did not correlate with any change in efficacy in field trials.  In 2013 17 
the Fungicide Resistance Action Committee (FRAC) reported that DMI field 18 
performance was good when used according to the manufacturers and FRAC 19 
recommendations.18  Despite anecdotal evidence of declines in field 20 
performance, no study has quantified a reduction in field efficacy for either 21 
epoxiconazole or prothioconazole that consistently reflects the in vitro data.  22 
There are two main explanations for the lack of a clear relationship 23 
between laboratory and field performance: Firstly, in vitro sensitivity 24 
phenotyping can detect small shifts in EC50 values, which may be too small to 25 
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change efficacy at doses typically used in the field, even if such strains are at 1 
high frequency.  Secondly, field experiments are subject to many extraneous 2 
variables that add uncertainty to measurements of efficacy, even if they are 3 
conducted to a consistent protocol across sites and seasons.  Error variation 4 
is caused by many environmental, treatment and assessment factors, such as 5 
differences in when fungicide treatments are applied (which can be weather 6 
dependent) relative to when specific culm leaf layers emerge and become 7 
infected.  The efficacy measured is highly dependent on the relationship 8 
between application timing, leaf emergence, infection events, the leaf layers 9 
that are subsequently assessed and the timing of those assessments.19 10 
The field experiments described here tested fungicide performance in the 11 
UK and Ireland, by a standard protocol, over two decades.  The analysis 12 
addressed some of the sources of extraneous variability described above, in 13 
order to improve the likelihood of detecting underlying relationships between 14 
laboratory and field performance.  Field performance was related to data from 15 
laboratory assays of Z. tritici isolates collected at a single location. 16 
Changes in field performance of the DMI and QoI modes of action, were 17 
quantified by fitted dose response curves of the form y=a+bekx, where y = % 18 
disease, x = dose, k quantifies the curvature, a the asymptote and a+b the 19 
untreated severity.19,20  From first principles, the relationships between 20 
changes in laboratory sensitivity and changes in field dose response curves 21 
might be expected to differ between qualitative and quantitative resistance.   22 
For example, with quantitative resistance against DMIs, estimated field 23 
ED50 (defined here as the dose which reduced severity to half of the untreated 24 
severity) values can be compared with laboratory mean EC50 values.  As 25 
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mutant variants arise resulting in a progressively wider and more shifted 1 
population distribution of sensitivities, the field dose response would be 2 
expected to become less strongly curved, resulting in changes to the 3 
curvature parameter k.  This is because, if many variants are slightly or 4 
moderately insensitive, control at lower doses would be more strongly affected 5 
than control at higher doses.  However, if a proportion of variants with high 6 
levels of insensitivity also arise, control at doses at, or close to, the maximum 7 
permitted dose may also be affected, resulting in a change of asymptote a, as 8 
a proportion of the pathogen population cannot then be controlled.   9 
For the contrasting case of qualitative resistance against QoIs, isolates are 10 
either sensitive or highly insensitive, so the hypothesis tested was that 11 
changes over years in the resistant proportion of the pathogen population 12 
would be expressed in the field as a change in the asymptote of dose 13 
response curves (representing the proportion of disease which cannot be 14 
controlled).  Understanding the relationships between these laboratory and 15 
field variables could help with the future translation of phenotypic or genotypic 16 
changes into field efficacy for new modes of action.   17 
 18 
2 EXPERIMENTAL METHODS  19 
 20 
2.1 Trials 21 
Eighty three field experiments were conducted between 1994 and 2015.  In 22 
each year (with exceptions in 1999 and 2000) between two and seven trials 23 
tested fungicide efficacy on Z. tritici.  DMI (epoxiconazole and 24 
prothioconazole) and QoI (azoxystrobin, trifloxystrobin and pyraclostrobin) 25 
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fungicides were applied once at one of four doses: 25%, 50% 75% and 100% 1 
of the maximum permitted dose (between 1994 and 1998); and 25%, 50%, 2 
100% and 200% of maximum dose (between 2001 and 2015) (Table 1).  One 3 
or two untreated control plots were included in each replicate.  Trials were 4 
sited at locations in England, Scotland and the Republic of Ireland known to 5 
suffer damaging epidemics of Z. tritici in most seasons.  Cultivars susceptible 6 
to STB but resistant to other diseases were selected to reduce confounding 7 
effects from other diseases.  Fungicides were applied when final leaf 1 (the 8 
flag leaf on the mature culm) was fully emerged, or leaf 2 (the leaf below) fully 9 
emerged or leaf 3 fully emerged, depending on the experiment.  Fungicides 10 
were applied by hand-held sprayer in 200-300 litres water ha-1 at 200-300 kPa 11 
pressure with a medium spray quality.  Minimum plot size was 20 m2 with 12 
three replicates, using either complete randomized blocks, or incomplete 13 
blocks using an alpha design.20 14 
 15 
2.1.1 Disease assessments  16 
Foliar diseases were assessed approximately 21 and 42 days after spray 17 
application.  Ten shoots were taken at random from each plot and each leaf 18 
layer scored for % leaf area affected.  Leaf layers were included in the 19 
analysis where mean untreated Z. tritici severity was between 3% and 70%, 20 
and a significant response to fungicides was observed.  The upper and lower 21 
limits on severity were imposed, based on judgement of experienced disease 22 
assessors, as very low and high severities are difficult to assess accurately. 23 
Severity data from a leaf layer in an experiment was classified as 24 
representing ‘protectant’ efficacy if the leaf had just emerged or was emerging 25 
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at the time of treatment.  Severity data from a leaf layer in an experiment was 1 
classed as representing ‘curative’ efficacy if the leaf layer had fully emerged 2 
10 days or more prior to treatment.  Curative data was included in the analysis 3 
from up to two leaf layers below the leaf which was fully expanded at the time 4 
of treatment, as infections on older leaf layers further down the canopy were 5 
likely to have already expressed disease symptoms, or be close to expressing 6 
symptoms, at the time of treatment.   7 
As the date of leaf emergence relative to the date of fungicide application 8 
can only provide an approximate guide to whether the leaf was likely to have 9 
latent infections at the time of treatment (and hence, whether the treatment 10 
was applied in a predominantly ‘protectant’ or ‘curative’ situation), an 11 
additional method of categorising the severity data was used, based on 12 
assessments from replicated ‘control’ plots in each experiment that were 13 
treated with 500 g/ha of chlorothalonil (as commercial product ‘Bravo 500’; 14 
Syngenta) which is a protectant fungicide.  If the control by chlorothalonil 15 
exceeded 60% efficacy on a leaf layer previously categorised at ‘curative’, 16 
then it was assumed that (due to environmental conditions) little infection of 17 
that leaf layer had occurred between emergence and treatments. Hence, the 18 
severity data from that leaf layer in that experiment was re-categorised as 19 
‘protectant’ for the analysis.  In the same way when control from chlorothalonil 20 
was found to be between 40% and 60%, on an ‘eradicant’ leaf, severity data 21 
was classified as mixed rather than eradicant, and was excluded from this 22 
analysis.     23 
 24 
2.2 In vitro sensitivity testing and genotyping 25 
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2.2.1 DMI sensitivity testing 1 
Ideally, to compare in vitro and field sensitivity, EC50 values should be 2 
obtained from samples of Z. tritici from multiple locations (including the 3 
locations of the field experiments) in a long run of consecutive years.  Due to 4 
resource limitations, such datasets do not exist in the public domain.  Instead, 5 
in vitro sensitivity data were used from sampling at one location in the UK in a 6 
sub-set of the years between 2003 and 2015.  To quantify variation in 7 
sensitivity across sites (for comparison against variation across years), data 8 
were obtained from samples from a range of UK locations taken in 2013 and 9 
2015.  Strains of Z. tritici were isolated and tested for fungicide sensitivity 10 
using optical density measurements of fungal spore growth in 96-well 11 
microtitre plates according to the method described by Cools et al. (2012). 12 
Before dilution in media, fungicides were dissolved in dimethylsulphoxide 13 
(DMSO).  All wells, including untreated, were adjusted with DMSO (final 14 
concentration 0.2% v/v in each well).  In vitro EC50 values
8 of Z. tritici were 15 
measured for epoxiconazole and prothioconazole from isolates collected from 16 
the same location in the UK (Rothamsted, Harpenden, UK) between 2003 and 17 
2015. Prothioconazole-desthio (an active metabolite) was used as a surrogate 18 
for prothioconazole.  In 2013, samples of populations were obtained for in 19 
vitro sensitivity analysis from Cambridgeshire, Shropshire, Hampshire, 20 
Herefordshire (2 populations sampled), Scotland, Kent and Hertfordshire 21 
(Rothamsted).  In 2015, samples of populations were obtained from 22 
Cambridgeshire (3 populations), Yorkshire (2), Herefordshire (2), 23 
Gloucestershire, Kent, Norfolk, Lincolnshire, Scotland, Hampshire and 24 
Hertfordshire (Rothamsted).   25 
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2.2.2 QoI G143A genotyping 1 
Isolates carrying the G143A QoI target site mutation have very high resistance 2 
factors, resulting in bi-modal population distributions of EC50 (comprising 3 
sensitive and insensitive sub-populations).  A mean EC50 for a population is 4 
not, therefore, a useful metric for the sensitivity of a population.  The 5 
frequency of G143A mutants in a population provides a metric which is more 6 
likely to relate to field performance, as the frequency represents the proportion 7 
of the pathogen population which will not be effectively controlled at any field 8 
dose. As reported by Fraaije et al., 2006 21 Z. tritici isolates were obtained, 9 
and genotyped for G143A, from untreated fields of winter wheat at 10 
Rothamsted, UK, at the start of each seasons in consecutive years from 2001 11 
to 2006, and in 2015.   12 
  13 
2.3 Data management and statistics 14 
Percent Z. tritici severity values were logit transformed and means calculated 15 
for each experiment.  Means across experiments were calculated after logit 16 
transformation by linear mixed model using REML (residual or restricted 17 
maximum likelihood), with fixed (treatment) and random (trial and year) 18 
effects.  Fungicide dose response curves were calculated from back 19 
transformed data using the exponential function y=a+bekx, where y = % 20 
disease, and x = proportion of full label rate.19,20  Results were analysed for  21 
QoI and DMI active substances for which several years of data were available 22 
(see Table 1), using GenStat Release 13.3.22 23 
Dose response curves were fitted to percent Z. tritici for the range of 24 
fungicide doses and converted into percent control to allow comparisons of 25 
efficacy between sites and seasons despite differences in untreated severity.  26 
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Possible effects of untreated severity on percent control were determined.  1 
 2 
3 RESULTS 3 
Dose response data were obtained every season for epoxiconazole (from 4 
1995) and prothioconazole (from 2001) until 2015 (Table 2), with the 5 
exception of 1999 and 2000 (when no experiments were conducted).  With 6 
few exceptions, each experiment produced dose response data which 7 
reflected predominantly curative control and protectant control, from 8 
assessments of lower and upper leaves of the crop canopy respectively.  9 
Exceptions to this were in 1998 when only curative dose response data were 10 
available; and in 2010 and 2015 only protectant dose responses were 11 
obtained (Table 2).  Chlorothalonil, as a control, was tested at 0.5 label rate in 12 
1995 to 1996 and 2003-2015, and there was no indication of a change in 13 
efficacy over this period.  The performance of the three QoI fungicides was 14 
quantified from between one and six dose responses in each of the five years 15 
reported here. 16 
 17 
3.1 QoI efficacy  18 
In 2001 and 2002, the QoI fungicides gave highly effective control of STB 19 
(Figure 1).  The dose response curves for trifloxystrobin and pyraclostrobin 20 
were highly curved, with percent control achieved at a quarter or half the 21 
maximum permitted dose being close to the asymptote value.  Similar 22 
patterns were seen in predominantly protectant and predominantly curative 23 
control, although the range of variability between the highest and lowest levels 24 
of control was greater where control was protectant. The across experiment 25 
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mean dose response for azoxystrobin was less tightly curved, reflecting less 1 
effective control at lower doses than the other QoI active substances. 2 
Between harvest years 2001 and 2005 a rapid decline in the control 3 
achieved was observed for all three QoI fungicides tested (Fig. 1).  The 4 
pattern of decline in activity was similar in both protectant and curative 5 
situations.  6 
 7 
3.2 Changes to the parameters of dose response curves for QoIs 8 
The main change in the dose response curves for QoI fungicides was a 9 
decrease through time in the overall level of control that was achievable, as 10 
represented by a decrease in the asymptote of the percent control curve 11 
between 2001 and 2005 (Fig. 2).  The changes in asymptotes were large in 12 
comparison with the standard errors on the parameter estimates, and 13 
regressions of asymptote on year were highly significant (p>0.001) in both 14 
protectant and curative situations accounting for 66.8% and 69.2% of the 15 
variation, respectively (Fig. 2).  There was no significant change in the 16 
curvature parameter k.  17 
 18 
3.3 DMI efficacy 19 
Epoxiconazole showed a gradual erosion of protectant activity and a steeper 20 
decline in curative activity over the 21 years that it has been tested (Fig. 3).  21 
Prothioconazole was tested over 15 years and followed a similar pattern of 22 
decline (Fig. 4).  In both actives the range between the best and worst efficacy 23 
observed within each group of seasons increased as mean efficacy declined.  24 
This was particularly evident, for example, when comparing protectant activity 25 
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between 2007-09 with activity between 2013-15, with epoxiconazole or 1 
prothioconazole.  The curves denoting best and worst efficacy are fitted to 2 
data from single experiments, so the data are variable.  3 
 4 
3.4 Changes to the parameters of dose response curves to DMI’s  5 
A significant reduction in the curvature parameter (k) was observed for dose 6 
responses to epoxiconazole and prothioconazole in both curative and 7 
protectant situations (Fig. 5).  There was considerable variation in the 8 
parameter estimates, both within and between seasons.  Nevertheless, 9 
differences between k values across years were large relative to the standard 10 
errors of the estimates and a regression of k on years was highly significant.  11 
The underlying shape of the relationship of k across years was difficult to 12 
discern, given the variability, however a linear model was the best fit, 13 
accounting for 38.5% of the variation (p<0.001, F test) (linear fit equation k = 14 
0.3122x-630.2, where x = year).  There was no improvement in explanatory 15 
power by estimating separate parameter values for the two actives or for 16 
predominantly curative or protectant applications.  17 
The asymptotes of the response curves for both of the DMI fungicides 18 
increased as a proportion of the untreated and this change across years was 19 
significant (Fig. 6).  The underlying shape of the change in asymptotes across 20 
years was uncertain due to variability of estimates, but approximated to a 21 
linear increase for both fungicides in both protectant and curative situations. 22 
The increases were different for each type of activity.  Separate parallel linear 23 
regressions for protectant treatments were statistically significant: explaining 24 
20.7% of the variation for the protectant data set (y=0.00814x–16.13 for 25 
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epoxiconazole, and y=0.00814x–16.20 for prothioconazole, p = 0.012, F test). 1 
In curative situations a single linear regression accounted for 35.9% of the 2 
variation (y=0.02366x-47.2, p <0.001 F test).  There was no significant 3 
improvement in explanatory power by fitting separate curves for the two 4 
products.  There was indication of a curvilinear response, but this was 5 
predominantly due to one year (2008) with high leverage.   6 
 7 
3.5 Relating in vitro sensitivity phenotype to field efficacy – DMI 8 
fungicides 9 
Between 2003 and 2015 mean in vitro EC50 of epoxiconazole for populations 10 
of Z. tritici sampled at Rothamsted increased 17 fold from 0.042 to 0.739 11 
micrograms per ml.  The equivalent increase for prothio desthio was 20 fold 12 
from 0.006 to 0.123 (Table 3). In the two years for which data are available 13 
from a range of UK locations (2013 and 2015) EC50 values varied 3 or 4 fold 14 
between populations sampled from different sites (Table 3) and the 15 
Rothamsted samples in those years were well within the range observed 16 
elsewhere.  The available data indicate that variation across years was 17 
substantially greater than variation across locations.  18 
The extent to which laboratory EC50 values might explain field ED50 values 19 
was tested by regression.  Laboratory EC50 values plotted in Fig 7 are those 20 
shown in Table 3.  Field ED50 values were estimated from the mean dose-21 
response curves for each year as the dose at which 50% control was 22 
obtained.  Significant relationships between laboratory and field values were 23 
found for both fungicides.  A regression of field on laboratory EC50 values for 24 
epoxiconazole was significant (p=0.01, F Test, SE=0.275) and accounted for 25 
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64.4% of the variation observed (y= 0.3128x -0.007 where y = log10 field 1 
ED50, and x=log10 in vitro EC50).  For prothioconazole, the relationship was 2 
also significant (p>0.001, F test, SE = 0.0952) explaining 79.5% of the 3 
variation (y= 3.812x +0.246, where y= field ED50, and x = in vitro EC50).  Field 4 
ED50 and laboratory EC50 values both increased in approximately year order 5 
from bottom left to top right of the scatter plots (Fig. 7).  For those years when 6 
field ED50 values could be estimated for curative and protectant situations, the 7 
two data points are not independent of each other, as each pair of y-axis 8 
values share a common x-axis value.  In each pair the dose required to 9 
achieve 50% control was higher in curative than protectant situations, but 10 
there were too few values to legitimately test whether separate regression 11 
intercepts or slopes were justified where control was predominantly curative 12 
rather than protectant.  13 
 14 
In vitro sensitivity is usually expressed as EC50 in units of concentration of 15 
active substance added to agar or liquid medium.  In principle, a stronger 16 
comparison of in vitro and field values would use concentration of active 17 
substance in leaves, so that both axes of the relationship were expressed in 18 
the same units.  However, in practice values for field concentrations are 19 
difficult to quantify analytically or calculate, because the applied dose of 20 
systemic active substances (measured in grams applied per unit ground area) 21 
subsequently moves in the xylem flow and becomes diluted in the volume of 22 
the crop canopy.  Field concentrations can be estimated by assuming that the 23 
proportion of the applied dose intercepted by each leaf layer within the upper 24 
crop canopy became diluted in a given leaf water content23.  Estimates of 25 
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fungicide deposition, on a leaf area basis were provided by F. Van den Berg 1 
(pers. comm.) based on a method published previously24.  Deposition on the 2 
upper most leaf (at the time of fungicide application) was assumed to 3 
approximate to predominantly protectant situations, and the average of two 4 
leaf layers below was assumed to approximate to deposition for curative 5 
situations.  These estimated concentrations (in micrograms per ml) were used 6 
to calculate EC50 values for each fungicide, using the mean dose response 7 
curve for each group of years.  Note that these values will be referred to as 8 
‘field EC50’ to distinguish them from field ED50 values expressed in relation to 9 
applied dose.  Using this method, significant relationships were found for both 10 
fungicides (Fig 8).  A regression of field on laboratory EC50 values for 11 
epoxiconazole was significant (p=0.014, F Test, SE=5.24) and accounted for 12 
60% of the variation observed (y= 51.2x+3.88 where y = field EC50, and x= in 13 
vitro EC50).  For prothioconazole, the relationship was also significant 14 
(p<0.001, F test, SE = 2.49) explaining 88.9% of the variation (y= 399.1x + 15 
6.36, where y= field EC50, and x = in vitro EC50).  In both fits the constant was 16 
not significantly different from zero. Slopes were much greater than one.   17 
 18 
3.6 Relating genotype frequency to field efficacy – QoI fungicides 19 
The frequency of the mutation underlying the target site G143A amino acid 20 
substitution increased rapidly from zero in 2001 and 2002 to 96% by 2006 21 
(Table 4).  A high frequency persisted to 2015.  The number of isolates 22 
genotyped was particularly low in the first two years, so low levels of G143A 23 
may have been present, but not detected.  Nevertheless, the frequencies 24 
reported here are similar to those reported by other workers 25 across Europe 25 
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over these critical years when there was rapid selection for insensitive strains.  1 
During the years when the population was in transition, the population 2 
distribution of sensitivities was bi-modal, comprising sensitive and insensitive 3 
sub-sets.  The insensitive G143A sub-set were characterised by very high 4 
resistance factors, indicating that they would not be controllable at any legal 5 
field dose.  Mean EC50 values are not a representative metric for bi-modal 6 
population distributions, so regression against field data was not attempted.  7 
The frequency of G143A in each year was well related to the asymptotes of 8 
the field dose response curves (Fig. 9).  Regression of field dose response 9 
asymptotes (across all QoI active substances) on frequency of G143A 10 
explained 88% and 78% of the variation in asymptote in protectant and 11 
curative situations, respectively.  Regression statistics for protectant data 12 
were p<0.01 by F Test, SE=0.091, y=0.0066x+0.1234, and for curative data 13 
were p<0.01 by F Test, SE=0.124, y=0.0059x+0.2385, where y=asymptote 14 
(dimensionless fraction) and x=frequency of G143A (%).   Strong cross-15 
resistance between QoI fungicides resulted in similar loss of efficacy for all 16 
active substances.  Differences in asymptotes between the fungicides, 17 
observed before G143A strains became common, probably relate to 18 
differences in inherent activity of the active substances.  Higher asymptotes in 19 
curative than protectant situations (Fig. 9.) were also observed before G143A 20 
became common.    21 
 22 
4 DISCUSSION  23 
The methodology used in the long-term run of experiments reported here 24 
ensured that the leaf layers in the canopy that were assessed were consistent 25 
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in relation to the uppermost leaf layer that was fully emerged at the time of 1 
fungicide application.  This approach reduces extraneous variability between 2 
sites and seasons, enabling underlying changes in efficacy to be quantified 3 
with greater precision.  The method also allowed differentiation between 4 
treatments that were predominantly controlling symptom expression from 5 
existing latent infections and treatments that were predominantly preventing 6 
new infections.  This distinction can never be absolute with naturally occurring 7 
epidemics, as each leaf layer at different points in time will contain some 8 
combination of uninfected, latent, infectious and post-infectious leaf area. 9 
Nevertheless, clear differences in the performance of the fungicides were 10 
found between protectant and curative situations, particularly in the later 11 
stages of DMI insensitivity evolution, when curative efficacy deteriorated 12 
markedly.  13 
The loss of QoI efficacy reported here is consistent with the loss reported from 14 
other parts of Europe 25 where QoI fungicides have also been widely used, 15 
resulting in selection for high frequencies of strains with the G143A 16 
cytochrome b mutated alleles.  The reduction in DMI performance reported 17 
here for the UK and Ireland was greater than reported elsewhere in 18 
Europe.26,27  This may be explained by differences in experimental and farm 19 
practice.  Many field experiments use two or more fungicide applications to 20 
measure efficacy.  In the experiments reported here, a single application was 21 
used to expose fungicides to a difficult control challenge (to better discriminate 22 
differences in performance between fungicides) and to distinguish between 23 
protectant and curative performance.  Trials with multiple applications may 24 
mask an underlying deterioration in curative performance.  The wet temperate 25 
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maritime climate in the UK and Ireland causes high epidemic growth rates of 1 
Z. tritici.  This has two evolutionary consequences: high epidemic growth rates 2 
cause faster rates of selection for insensitive strains, and growers respond to 3 
high disease risk by increased fungicide use, further increasing the rate of 4 
selection.28  5 
There was a different pattern in the decline in field performance of the DMIs 6 
compared to the QoI’s, as expressed through changes in dose response 7 
parameters.  The control achieved from the use of QoIs in the UK and Ireland 8 
reduced significantly between 2001 and 2005.  This decline was well related 9 
to the increase in frequency of the G143A mutation in the UK, reported to 10 
confer a high level of insensitivity to QoI fungicides.5  During this period the 11 
QoIs went from providing between 60% and 100% control, to less than 40% 12 
control of Z. tritici on average.  Despite the G143A mutation being found in 13 
90% of the UK population by 2005, some residual activity from QoIs on Z. 14 
tritici remained.  This agrees with work showing that the QoI pyraclostrobin 15 
may still have an effect on G143A strains through a reduction in germ tube 16 
extension.29  The results here indicate that this residual control may not be 17 
limited to just protectant activity.  The G143A mutation split Z. tritici into two 18 
sub-populations.  The wild type sub-population remained sensitive to field 19 
doses, whereas the mutant sub-population was resistant to doses above the 20 
maximum permitted field dose.  The dose response asymptotes reported here 21 
were estimated from a range of field doses below those which would control 22 
the G143A sub-population.  Although the asymptote, in theory, represents 23 
maximum control with infinite dose, in reality the difference between the 24 
untreated value and the asymptote represents control of the wild-type strains 25 
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and the asymptote measures a combination of the proportion of the pathogen 1 
population that carries the mutation, plus wild-type lesions which cannot be 2 
controlled because they are not in a sensitive stage of their life cycle at the 3 
time of treatment. The changes in asymptote values were a good reflection of 4 
the changes in G143A frequency.     5 
The pattern of decline in DMIs differed substantially from that seen in the 6 
QoIs, both in relation to the speed of change in efficacy and in the dose 7 
response parameters affected.  These were consistent with the effect of a 8 
succession of insensitivity changes of small effect, accumulating over many 9 
years.30  The decline in efficacy was primarily associated with a change in 10 
dose response curvature. Mutant strains which have low or moderate 11 
resistance factors (mutant strain EC50 divided by wild type EC50) are likely to 12 
remain sensitive to doses near the maximum permitted field dose, but be 13 
insensitive to lower doses, resulting in an observed reduction in field dose 14 
response curvature.  The effect on curvature is complicated by the great 15 
diversity of insensitive variants and by variation in the deposition of dose at 16 
different points in crop canopies.31  That the asymptote of DMI response 17 
curves was also decreasing, more especially in curative situations, suggests a 18 
proportion of the Z. tritici population may now be beyond control at field rates 19 
of DMI application.  This agrees with the latest laboratory results showing that 20 
the most evolutionarily advanced strains of Z. tritici, carrying complex CYP51 21 
variants with multiple amino acid alterations, often in combination with over-22 
expression of CYP51 and efflux mechanisms, have DMI resistance factors of 23 
similar order to QoI resistant G143A strains.3  These advanced strains have 24 
yet to dominate the population in the same way as QoI resistant mutants do.12  25 
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The balance of fitness benefit when exposed to DMI and fitness dis-benefit 1 
when not exposed, may slow the rate of displacement of more moderately 2 
insensitive strains which already dominate the population. 3 
The impact of insensitive strains on particular parameters of dose response 4 
curves in particular situations has practical implications for growers seeking to 5 
control disease effectively.  In the QoI case, the deterioration in control, at all 6 
doses in both protectant and curative situations, was so dramatic that usage 7 
against STB fell substantially and growers switched to higher use of other 8 
modes of action against STB, particularly the multi-site acting fungicide 9 
chlorothalonil.32  QoIs remain effective against wheat rusts so retain a value in 10 
wheat fungicide programmes.   11 
The change in DMI sensitivity, field efficacy and the resulting change in 12 
grower behaviour, was different from the QoI case.  The straightening of DMI 13 
response curves caused growers to respond by using higher DMI doses to 14 
maintain control, and the reduction in curative performance resulted in more 15 
frequent applications to maximise protectant effect.33  Whether this increase in 16 
usage was economically justified has yet to be adequately tested.    17 
The work reported here has demonstrated, for the first time, a significant 18 
relationship between laboratory EC50 and field ED50 values for Z. tritici when 19 
field EC50 was expressed in units of proportion of maximum permitted dose.  20 
The relationship was significant despite the in vitro data representing the 21 
sensitivity of the Z. tritici population at one location (Rothamsted) and the field 22 
data representing fungicide performance against populations at multiple sites 23 
across England, Scotland and Ireland.  High levels of gene flow 30 may have 24 
resulted in changes in the sensitivity of the population at Rothamsted being 25 
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broadly representative of changes in sensitivity of populations at other 1 
locations.  This interpretation is supported by the range of variation in EC50 2 
values between a long run of years being substantially higher than the range 3 
of variation across UK locations within a year.  A persistent difference in the 4 
frequency of particular CYP51 genotypes between Ireland and the UK, did not 5 
result in the Irish field experiment data deviating notably from the general 6 
relationships between in vitro EC50 and field ED50.  Such a deviation may have 7 
occurred if other active substances had been tested.  A wider geographic 8 
spread of samples for in vitro sensitivity phenotyping, and a continuous run of 9 
seasons with the phenotyping conducted to the same methods, would be 10 
desirable if resources permitted.   11 
A significant relationship between laboratory and field EC50 values was also 12 
found where both axes were expressed in the same units by estimating field 13 
EC50 values as estimated fungicide concentration in leaves.  Despite 14 
simplifying assumptions in the underlying calculation of fungicide 15 
concentrations in the crop canopy, the intercepts of the relationships were 16 
close to (and not significantly different from) the origin, which adds confidence 17 
to the predictive value – albeit that the ‘prediction’ was retrospective.   18 
As might be expected, higher fungicide concentrations were required in the 19 
field than in the laboratory to achieve the same proportional level of control. 20 
For epoxiconazole and prothioconazole comparable levels of control required 21 
approximately 50 and 400 times higher concentration in the field respectively, 22 
compared to laboratory assays  The high value for prothioconazole may also 23 
result from the use of the more active metabolite prothioconazole-desthio in 24 
the in vitro tests.34  Other factors are: (i) all of the dose being added to liquid 25 
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medium of the laboratory assay immediately before inoculation, compared to 1 
the field situation where infection may occur before, or many days after, 2 
treatment, (ii) losses of active substance to the air and soil during field spray 3 
application, (iii) spatial variation in the applied dose to different parts of the 4 
crop canopy, and (iv) slow decay of fungicide dose in vitro, compared to the 5 
field where UV exposure and in planta metabolism increase decay.    6 
The relationship between laboratory assays and field performance found 7 
here, supports the use of laboratory assays on new insensitive strains as an 8 
indicator of future changes in field performance.  A key question is: to what 9 
extent might a relationship between laboratory assay and field performance 10 
for one mode of action be predictive for future cases of resistance against 11 
other modes of action?  For example, the results from this study suggest that 12 
a change of mean laboratory EC50 of ten-fold or more (compared to a baseline 13 
population of sensitive wild types) has the potential to result in a practically 14 
important change in field efficacy and in the field dose required to achieve 15 
effective control.  Does this imply that recently found35 SDHI insensitive 16 
strains of Z. tritici with resistance factors of ten or more will impact on field 17 
performance? A point in favour of the results being generalizable is that the 18 
effect on performance depends on the insensitivity phenotype, rather than 19 
being specific to particular underlying genotypic changes or mode of action.  20 
In principle, if the baseline dose response curves for two fungicides are 21 
similar, then similar changes of sensitivity phenotype should result in similar 22 
changes to field efficacy.   23 
A predictive difficulty remains however.  New strains may demonstrate a 24 
ten- or hundred-fold shift of in vitro sensitivity, but it is uncertain whether they 25 
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will increase in frequency sufficiently to cause a ten- or hundred-fold shift in 1 
the sensitivity distribution of the field population.  The fitness advantage over 2 
wild-type strains, which drives selection in the presence of fungicide, is 3 
indicated by the in vitro sensitivity of new strains.  But fitness costs in the 4 
absence of fungicide, measured in the laboratory or glasshouse, have yet to 5 
be adequately associated with selection against new strains in the field.  Field 6 
experiments, of the type reported here, can measure efficacy changes 7 
between years and potentially relate laboratory or glasshouse fitness 8 
measurements (either an increase in fitness in the presence of the fungicide 9 
or a decrease in fitness in the absence of the fungicide) to field efficacy. 10 
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Table 1.  Fungicides tested and included in this analysis.  Other products were 
included in the experiments, but excluded from the long-term analysis as they were 
tested for insufficient years.  Product names and concentrations changed over the 
course of the project; however, the amount of active ingredient in a full label rate of 
each active remained the same. a.s. is active substance. c.p. is commercial product 
Active 
substance (a.s.) 
Product 
name 
grams of a.s. 
litre-1 c.p. 
Full dose 
 l of c.p. ha-1 
Company Years in 
trials 
epoxiconazole  Opus / 
Ignite 
125 / 83 1.0 /1.5 BASF 1995-1998, 
2001-2015 
prothioconazole Proline / 
Proline275 
250 / 275 0.8 / 0.72 Bayer 2001-2015 
azoxystrobin  Amistar 250 1.0 Syngenta 1997-1998, 
2001-2006 
pyraclostrobin  Comet / 
Vivid 
250  1.0 BASF 2001-2005, 
2007 
trifloxystrobin  Swift 500 0.5 Bayer 2001-2005 
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Table 2.  Total number of field experiments providing dose response data 
from predominantly curative or protectant fungicide applications. Note that one 
experiment may produce both curative and protectant data, from lower and 
upper leaf layers in the crop canopy, respectively. 
Active substance Years 
reported 
No. of 
seasons 
Protectant Curative 
azoxystrobin 2001-2005 5 8 7 
trifloxystrobin  2001-2005 5 19 14 
pyraclostrobin  2001-2005 5 19 13 
epoxiconazole 1995 -2015 19 73 49 
prothioconazole  2001- 2015 15 66 40 
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Table 3.  Mean EC50 values (micrograms per ml) for epoxiconazole and prothio-
desthio (as a surrogate for prothioconazole) for wild type sensitive Z. tritici, and 
populations of Z. tritici sampled in a sub-set of years between 2003 and 2015 at 
Rothamsted, UK (values in rows labelled single location). In 2013 and 2015 
samples were taken from 8 (2013) and 15 (2015) Z. tritici populations at sites 
across the UK.  The highest and lowest mean EC50 values from any population 
sampled are given in the rows labelled multiple locations.   
 
Active 
substance 
 Wild 
type 
2003 2008 2012 2013 2014 2015 
         
Epoxi Single 
location 
0.0029 0.042 0.101 0.396 0.276 0.311 0.739 
         
 Highest of 
multiple 
locations 
    0.92  1.355 
         
 Lowest of 
multiple 
locations 
    0.235  0.401 
         
Prothio- 
desthio 
Single 
location 
0.0014 0.006 0.01 0.051 0.044 0.065 0.123 
         
 Highest of 
multiple 
locations 
    0.145  0.267 
         
 Lowest of 
multiple 
locations 
    0.036  0.081 
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Table 4.  Frequency (%) of the G143A mutation, conferring insensitivity against 
QoI fungicides, in isolates of Z. tritici sampled at Rothamsted, UK, in a sub-set of 
years from 2001 to 2015.  Samples were taken in consecutive years during the 
period of rapid selection for insensitive strains.    
 
 2001 2002 2003 2004 2005 2006 2015 
        
Frequency 
(%) 
0 0 32 79 90 96 100 
        
Number of 
isolates 
sampled 
(n) 
9 10 90 58 48 54 53 
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Figure 1.  Comparison of QoI efficacy on Z. tritici in 2001-02 and 2004-2005 2 
with three QoI fungicides trifloxystrobin (A), azoxystrobin (B), and 3 
pyraclostrobin (C) in curative (left) and protectant (right) situations.  Solid lines 4 
and squares represent the mean % control achieved; dotted lines and + and x 5 
symbols represent the highest and lowest % control achieved respectively 6 
across the field experiments in each group of years.  n= the number of field 7 
experiments generating dose responses within each group of years.  8 
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 1 
 2 
 3 
Figure 2.  Changes in the asymptote (a) of the QoI dose response curves 4 
over time.  Asymptote values represented as a proportion of untreated (a+b).  5 
A = protectant situations.  B = curative situations. Symbols denote the 6 
products tested in each year.  Triangles: azoxystrobin, diamonds: 7 
pyraclostrobin, crosses: trifloxystrobin. Error bars show the standard errors for 8 
the asymptote estimates for each product and year.     9 
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For Peer Review  1 Figure 3.  Percent control of Z. tritici with epoxiconazole in curative and protectant situations between 1995-97 and 2013-15.  Solid 2 
lines represent the mean % control achieved; dotted lines the highest and lowest % control achieved across trials within each group 3 
of years. n= the number of trials generating dose responses in each group of years.  4 
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Figure 4.  Percent control of Z. tritici with prothioconazole in curative and protectant situations between 2001-03 and 2013-15.  1 
Solid lines represent the mean % control achieved across trials within each group of years; dotted lines the highest and lowest % 2 
control achieved and n= the number trials generating dose responses, in each group of years. 3 
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 1 
Figure 5.  The change in curvature parameter estimates for protectant and 2 
curative situations between 1995 and 2015, based on mean curve fits for each 3 
year, in both situations (crosses: epoxiconazole, diamonds: prothioconazole).  4 
Error bars indicate standard errors for each product in each year5 
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 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
Figure 6.  The increase in the asymptote (a) as a proportion of untreated 9 
(a+b) of dose response curves for epoxiconazole (crosses) and 10 
prothioconazole (diamonds), in protectant (A) and curative (B) situations, 11 
based on mean curve fits for each season.  Dotted line shows the regression 12 
for prothioconazole, dot-dash line shows epoxiconazole in A, and solid line 13 
shows both in B.  Error bars indicate standard errors.  14 
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 1 
 2 
Figure 7.  The relationship between mean in vitro EC50’s and field ED50’s (as 3 
a proportion of full label rate) for epoxiconazole (A), and for prothioconazole 4 
(B). In vitro EC50 tests used prothio-desthio as a surrogate for 5 
prothioconazole. Crosses: protectant field activity, triangles; curative activity.  6 
In vitro EC50’s are available for 2003, 2008, 2012, 2013, 2014 and 2015.  ED50 7 
field values were not achieved at any dose in curative situations for 8 
epoxiconazole in 2012, and epoxiconazole and prothioconazole in 2013 and 9 
2014 (no field curative activity was recorded in 2015).   10 
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 1 
2 
Figure 8.  The relationship between mean in vitro EC50 values and estimated 3 
field EC50 values for epoxiconazole (A) R2=0.63, SE=4.84, and for 4 
prothioconazole (B) with in vitro EC50 tests of prothio-desthio (as a surrogate 5 
for prothioconazole) R2=76.6, SE 6.09. Crosses: protectant field activity, 6 
triangles; curative activity.  In vitro EC50 values are available for 2003, 2008, 7 
2012, 2013, 2014 and 2015.  EC50 field values were not achieved (as the 8 
required level of control was not achi ved) in curative situations for 9 
epoxiconazole in 2012, or for epoxiconazole and prothioconazole in 2013 and 10 
2014 (curative activity data were not obtained in 2015).   11 
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 3 
Figure 9.  Relationships between asymptotes (a) of QoI dose response 4 
curves and G143A frequency (%) between 2001 and 2005.  Asymptote values 5 
are expressed as a proportion of untreated severity (a+b).  A = protectant 6 
situations.  B = curative situations. Symbols denote the products tested.  7 
Triangles: azoxystrobin, diamonds: pyraclostrobin, crosses: trifloxystrobin. 8 
Error bars show the standard errors for the asymptote estimates for each 9 
product and year.     10 
Page 46 of 47
http://mc.manuscriptcentral.com/pm-wiley
Pest Management Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2 
 
 1 
Page 47 of 47
http://mc.manuscriptcentral.com/pm-wiley
Pest Management Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
